EUS-guided gastroenterostomy versus duodenal self-expandable metal stent for malignant gastric outlet obstruction: results from a nationwide multicenter retrospective study (with video)

医学 胃肠造口术 胃出口梗阻 支架 恶性肿瘤 危险系数 自膨胀金属支架 回顾性队列研究 外科 覆膜支架 姑息治疗 癌症 内科学 胃切除术 置信区间
作者
Rubén Sánchez-Aldehuelo,José Carlos Subtil Iñigo,Belén Martínez‐Moreno,Joan B. Gornals,Carlos Guarner–Argente,Alejandro Repiso Ortega,Sandra Peralta Herce,José Ramón Aparicio,Enrique Rodríguez de Santiago,Sergio Bazaga,Diego Juzgado,Fernando González-Panizo,Agustı́n Albillos,Enrique Vázquez-Sequeiros
出处
期刊:Gastrointestinal Endoscopy [Elsevier BV]
卷期号:96 (6): 1012-1020.e3 被引量:24
标识
DOI:10.1016/j.gie.2022.07.018
摘要

Traditionally, palliative treatment of malignant gastric outlet obstruction (GOO) has been surgical, but surgical treatment carries significant morbidity and mortality rates. Endoscopic placement of a duodenal self-expandable metal stent (D-SEMS) has been proven to be successful for this indication in the short term. However, D-SEMSs are likely to malfunction over time. EUS-guided gastroenterostomy (EUS-GE) may help overcome these limitations. We aimed to evaluate stent failure-free survival at 3 months.A nationwide multicenter, observational study of D-SEMS and EUS-GE procedures for patients with malignant GOO was conducted at 7 academic centers from January 2015 to June 2020. Stent failure-free survival at 1, 3, and 6 months; technical and clinical success; adverse events (AEs); and patient survival were evaluated in both groups and compared.Ninety-seven patients were included in the D-SEMS group and 79 in the EUS-GE group. Pancreatic cancer was the main underlying malignancy in 53.4%. No statistically significant differences regarding technical (92.8% vs 93.7%) or clinical success (83.5% vs 92.4%) were found. AE rates did not differ between groups (10.3% vs 10.1%), although 2 events in the EUS-GE group required surgical management. Patients in the EUS-GE group had improved stent patency when compared with those patients in the D-SEMS group at 3 months (92.23% vs 80.6%; adjusted hazard ratio, .37; P = .033).EUS-GE seems to have improved patency outcomes when compared with D-SEMS placement for palliative treatment of malignant GOO. Prospective trials are needed to fully compare their efficacy and AE profile.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
欣喜眼神发布了新的文献求助10
1秒前
SYLH应助坦率莫言采纳,获得10
2秒前
2秒前
科研白菜发布了新的文献求助10
3秒前
打打应助欣喜的冥王星采纳,获得10
3秒前
3秒前
4秒前
绿波电龙发布了新的文献求助150
4秒前
白杨木影子被拉长完成签到,获得积分10
5秒前
冷静发布了新的文献求助10
5秒前
5秒前
zzzz发布了新的文献求助10
5秒前
5秒前
我是老大应助欣喜眼神采纳,获得10
6秒前
雪落你看不见完成签到,获得积分10
6秒前
嘿嘿应助LYB吕采纳,获得10
7秒前
8秒前
Qwe发布了新的文献求助10
9秒前
隐形曼青应助宋宋采纳,获得10
10秒前
田様应助45采纳,获得10
10秒前
蜂蜜罐zi完成签到,获得积分10
11秒前
搜集达人应助魏少爷采纳,获得10
11秒前
FashionBoy应助冬至季采纳,获得10
11秒前
Yuntao_Chen发布了新的文献求助10
11秒前
11秒前
鸭梨鸭梨发布了新的文献求助10
14秒前
14秒前
火星上书本完成签到,获得积分20
15秒前
科研通AI2S应助sciDoge采纳,获得10
16秒前
吴祥坤发布了新的文献求助10
16秒前
17秒前
量子星尘发布了新的文献求助10
19秒前
19秒前
19秒前
19秒前
20秒前
感谢大家完成签到,获得积分10
21秒前
WQ发布了新的文献求助10
22秒前
hai完成签到,获得积分10
23秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975814
求助须知:如何正确求助?哪些是违规求助? 3520123
关于积分的说明 11201020
捐赠科研通 3256502
什么是DOI,文献DOI怎么找? 1798347
邀请新用户注册赠送积分活动 877523
科研通“疑难数据库(出版商)”最低求助积分说明 806417